| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,152 |
12,742 |
$957K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,048 |
2,791 |
$271K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,282 |
2,165 |
$224K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,254 |
1,185 |
$130K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
957 |
899 |
$94K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,354 |
4,052 |
$94K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,429 |
2,194 |
$90K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,752 |
5,279 |
$71K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
211 |
102 |
$21K |
| 96127 |
|
1,848 |
1,691 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
157 |
149 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
237 |
224 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
85 |
79 |
$8K |
| 99177 |
|
667 |
637 |
$3K |
| 90473 |
|
184 |
181 |
$2K |
| 90670 |
|
1,079 |
1,025 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
51 |
45 |
$2K |
| 90698 |
|
1,131 |
1,068 |
$798.06 |
| 83655 |
|
52 |
50 |
$724.45 |
| 36416 |
|
160 |
146 |
$520.57 |
| 87807 |
|
31 |
30 |
$450.64 |
| 90686 |
|
1,762 |
1,604 |
$371.67 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19 |
16 |
$339.32 |
| 85018 |
|
95 |
88 |
$244.91 |
| 99000 |
|
55 |
51 |
$182.76 |
| 99188 |
|
12 |
12 |
$129.72 |
| 90680 |
|
223 |
218 |
$126.58 |
| 96161 |
|
29 |
29 |
$107.44 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$94.22 |
| 90744 |
|
40 |
38 |
$4.26 |
| 90671 |
|
43 |
43 |
$0.00 |
| 90633 |
|
29 |
29 |
$0.00 |
| 99072 |
|
13 |
12 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
12 |
12 |
$0.00 |